Aphena Pharma Solutions announced it has expanded its solid-dose packaging operations in Cookeville, TN. The expansion doubled the size of the facility, increasing manufacturing and warehouse space, and...
Mayo Clinic receives patent for GeneSight
May 22, 2013
The Mayo Clinic has received a patent for a new medication selection procedure. GeneSight uses a test to prioritize the selection of medications for patients with depression, chronic pain and other psychiatric...
Winners announced for Scheduler of the Year
Apr 11, 2017
OnShift has announced the winners of its annual Scheduler of the Year Awards last week.
Seroquel generics okay, appeals court says
May 01, 2013
AstraZeneca is not entitled to more exclusivity with its antischizophrenic medication, an appeals court agreed last week. The company had claimed its drug, Seroquel, deserved another three-year extension...
AccentCare acquired
By
Elizabeth Newman
May 22, 2019
Advent International announced it will acquire post-acute healthcare company AccentCare Inc. from private equity firm Oak Hill Capital Partners.
Lung cancer mutation test approved
May 29, 2013
The U.S. Food and Drug Administration has given premarket approval to the cobas® EGFR Mutation Test from Roche Molecular Systems, creating a possible future option for metastatic lung cancer patients.
Webster Printing responds to COVID-19
By
Kimberly Marselas
Apr 01, 2020
A commercial printing and sign company has launched a new division dedicated to social distancing sign solutions. Massachusetts-based Webster Printing offers an in-house design and creative services team...
McKesson Health Solutions unveils InterQual 2015
May 19, 2015
McKesson Health Solutions has introduced InterQual® 2015, the latest edition of the company’s decision-support solution.
New finance deals for senior facilities
Aug 28, 2013
Berkadia Commercial Mortgage LLC has originated $172.1 million in financing for four Brookdale Senior Living communities.
Robotic treatment for patients with spinal injuries newly available
Mar 13, 2018
A “revolutionary” new robotic treatment for patients who have suffered spinal cord injuries, first developed in Japan, is now available in the U.S.